Sign In
Buy GENE
$0.765
+0 (+0%)
At Close: Jan 15, 2025
Genetic Technologies Announces Pricing of $8.… Million Public Offering
12:00am, Tuesday, 26'th May 2020Genetic Technologies Provides Operational Update - Successful Prototype Polygenic Risk Score for COVID-19 Created
08:05pm, Friday, 22'nd May 2020
To accompany that process, the Company will be working with its Consumer Initiated Testing (CIT) platform supplier to generate online product content to support sales activities in the USA. Leveragin
Genetic Technologies Provides Operational Update - Successful Prototype Polygenic Risk Score ...
12:00am, Friday, 22'nd May 2020Genetic Technologies - Accelerated development of new COVID-19 Polygenic Risk Test for Risk of Developing Life-Threatening Complications
01:15pm, Wednesday, 20'th May 2020
Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) is to commence accelerating development of a polygenic risk score (PRS) test to predict an individual’s risk of developing life-threatening comp
Genetic Technologies - Accelerated development of new COVID-–9 Polygenic Risk Test for Risk ...
12:00am, Wednesday, 20'th May 2020Genetic Technologies Says Nasdaq Hearing Panel Grants Full Extension for Continued Listing
09:16am, Monday, 18'th May 2020Genetic Technologies Announces Closing of $1.44 Million Registered Direct Offering
12:00pm, Thursday, 23'rd Apr 2020
Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a leader in the development of genetic risk assessment tests, today announced the closing of its previously announced registe
